Doravirine, the Glossary

Table of Contents

1. 9 relations: Combination drug, Doravirine/lamivudine/tenofovir, European Medicines Agency, Food and Drug Administration, Health Canada, HIV/AIDS, Merck & Co., Oral administration, Reverse-transcriptase inhibitor.

2. Non-nucleoside reverse transcriptase inhibitors

Combination drug

A combination drug or a fixed-dose combination (FDC) is a medicine that includes two or more active ingredients combined in a single dosage form.

See Doravirine and Combination drug

Doravirine/lamivudine/tenofovir

Doravirine/lamivudine/tenofovir, sold under the brand name Delstrigo, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. Doravirine and Doravirine/lamivudine/tenofovir are Antiinfective agent stubs and drugs developed by Merck & Co..

See Doravirine and Doravirine/lamivudine/tenofovir

European Medicines Agency

The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products.

See Doravirine and European Medicines Agency

Food and Drug Administration

The United States Food and Drug Administration (FDA or US FDA) is a federal agency of the Department of Health and Human Services.

See Doravirine and Food and Drug Administration

Health Canada

Health Canada (HC; Santé Canada, SC)Health Canada is the applied title under the Federal Identity Program; the legal title is Department of Health.

See Doravirine and Health Canada

HIV/AIDS

The human immunodeficiency virus (HIV) is a retrovirus that attacks the immune system.

See Doravirine and HIV/AIDS

Merck & Co.

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of which it was once the American arm.

See Doravirine and Merck & Co.

Oral administration

| name.

See Doravirine and Oral administration

Reverse-transcriptase inhibitor

Reverse-transcriptase inhibitors (RTIs) are a class of antiretroviral drugs used to treat HIV infection or AIDS, and in some cases hepatitis B. RTIs inhibit activity of reverse transcriptase, a viral DNA polymerase that is required for replication of HIV and other retroviruses.

See Doravirine and Reverse-transcriptase inhibitor

See also

Non-nucleoside reverse transcriptase inhibitors

• Atevirdine
• Cabotegravir/rilpivirine
• Dapivirine
• Delavirdine
• Discovery and development of non-nucleoside reverse-transcriptase inhibitors
• Doravirine
• Efavirenz
• Elsulfavirine
• Emivirine
• Etravirine
• Fosdevirine
• Nevirapine
• Rilpivirine

References

[1] https://en.wikipedia.org/wiki/Doravirine

Also known as C17H11ClF3N5O3, MK-1439, Pifeltro.